DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Ausgabe 01 · Volume 57 · Januar 2019 DOI: 10.1055/s-008-42145

Deutsche Arbeitsgemeinschaft zum Studium der Leber (GASL)
35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Heidelberg, 22.–23.02.2019

Kongresspräsident: Prof. Dr. Ralf Bartenschlager
Abstracts (HTML) Autorenliste
P2.1
Al-Saeedi, M; Khajeh, E; Ghamar Nejad, O; Hoffmann, K; Stojkovic, M; Weber, T; Junghanss, T; Büchler, MW; Mehrabi, A: Endocystectomy technique for surgical treatment of hepatic cystic echinococcosis
P2.2
Al-Saeedi, M; Ghamarnejad, O; Khajeh, E; Sabagh, M; Shafiei, S; Majlesara, A; Mehrabi, A: The effect of Pringle maneuver in surgical outcome in patients underwent extended hepatectomy
P2.3
Backhus, J; Brinz, S; Seufferlein, T; Zizer, E: Der Einsatz einer permanenten Aszitesdrainage bei Patienten mit therapierefraktärem Aszites bei Peritonealkarzinose und end-stage-Leberzirrhose: Vergleich des Komplikationen- und Sicherheitsprofils
P2.4
Berger, A; Backhus, J; Seufferlein, T; Daniel, S; Zizer, E: Evaluation des Stellenwertes der cfDNA-Serumkonzentration für portale Hypertension bei Leberzirrhose
P2.5
Bettinger, D; Sturm, L; Pfaff, L; Giesler, M; Schmidt, A; Boettler, T; Weiss, KH; Heinzow, H; Thimme, R; Schultheiss, M: An alternative model for prediction of transplant-free survival in patients with implantation of transjugular intrahepatic portosystemic shunt (TIPS): The Freiburg risk score
P2.6
Büchter, M; Kersting, S; Willuweit, K; Gerken, G; Kahraman, A: Enzymatic liver function measured by LiMAx – a reliable diagnostic tool in chronic liver disease
P2.7
Buechter, M; Gerken, G; Kahraman, A: Characteristics and outcome of 544 patients with autoimmune hepatitis (AIH) – a single centre experience
P2.8
Byrtus, A; Bastgen, D; Byrtus, J; Trebicka, J; Treitl, M; Sauerbruch, T; Schultheiss, M; Rasenack, J; Thimme, R; Jacobs, S; Grandt, D; Rössle, M: Varizenblutung oder Aszites: Was bewirkt den Unterschied?
P2.9
Elshaarawy, O; Mueller, J; Guha, IN; Chalmers, J; Harris, R; Thiele, M; Madsen, BS; Krag, A; Stefanescu, H; Stancu, O; Mueller, S: Spleen to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications
P2.10
Goetze, O; Lee, SH; Kircher, M; Buck, A; Kickuth, R; Lapa, C; Geier, A: Effect of selective internal radiation therapy (SIRT) in patients with unresectable primary or metastatic liver tumors on microsomal liver function by means of 13C-methacetin breath test (MBT)
P2.11
Grandt, J; Parsberg Werge, M; Kimer, N; Møller, S; Trebicka, J; Gluud, LL: The CLIF-C AD-score predicts mortality in patients with non-decompensated cirrhosis
P2.12
Hagel, C; Andreas, T; Matthias, E; Svetlana, H; Antoni, C: Nierenperfusion und -steifigkeit als Marker unterschiedlicher renaler Auswirkungen der Leberzirrhose
P2.13
Hamesch, K; Atkinson, SR; Spivak, I; Guldiken, N; Theurl, I; Zoller, H; Trautwein, C; Thursz, MR; Strnad, P: In severe alcoholic hepatitis, serum transferrin predicts mortality independently of disease severity
P2.14
Hamesch, K; Guldiken, N; Aly, M; Hueser, N; Hartmann, D; Trautwein, C; Mueller, S; Nahon, P; Ziol, M; Bruns, T; Strnad, P: Serum CYFRA 21 – 1 levels are elevated in advanced liver disease and associate with poor survival
P2.15
Heintz, L; Holz, R; Weber, SN; Lammert, F; Krawczyk, M: Liver fibrosis in conjunction with the prosteatotic PNPLA3 variant affects quality of life in patients with NAFLD: prospective liver stiffness-based study
P2.16
Hoffmann, K; Khajeh, E; Ghamarnejad, O; Nikdad, M; Mohammadikhajehdehi, S; Golriz, M; Mehrabi, A: Meta-analysis of the efficacy of preoperative biliary drainage in hilar cholangiocarcinoma
P2.17
Hofmann, WP; Schattenberg, JM; Weber, SN; Heintz, L; Schubert, L; Dikopoulos, N; Schwenzer, J; Muche, M; Heyne, R; Ingiliz, P; Schmidt, A; Stein, K; Krawczyk, M; Roeb, E; Manns, MP; Zeuzem, S; Lammert, F; Buggisch, P: Baseline patient characteristics of the German multicentric prospective real-world NAFLD cohort: The Fatty Liver Assessment in Germany (FLAG) study
P2.18
Jud, A; Menzel, M; Jöchle, K; Kook, L; Neeff, HP; Lang, SA; Fichtner-Feigl, S; Ruf, J; Schiller, F; Sörensen, A: Comparing 99mTc-mebrofenin scintigraphy and LiMAx-Test to assess presurgical functional liver capacitiy before major liver resection
P2.19
Junger, H; Fichtner-Feigl, S; Schlitt, HJ; Laszik, Z; Brunner, SM: Induction of biliary epithelial wound healing and angiogenesis through IL6 in donor bile ducts after liver transplantation
P2.20
Krawczyk, M; Niewiadomska, O; Jankowska, I; Jankowski, K; Gozdowska, J; Lebensztejn, D; Wiecek, S; Lütjohann, D; Socha, P; Lammert, F: Common variant p.D19 H of the hepatobiliary sterol transporter ABCG5/8 increases the gallstone risk and affects cholesterol homeostasis in children
P2.21
Langholm, L; Zhang-Hagenlocher, C; Voitl, R; Klöters-Plachky, P; Sauer, P; Weiss, KH; Manon-Jensen, T; Rupp, C: Evaluation of serological markers of extracellular matrix remodeling in primary sclerosing cholangitis
P2.22
Laschtowitz, A; Zenouzi, R; Hartl, J; Sebode, M; Liwinski, T; Piecha, F; Weiler-Normann, C; Lohse, AW; Schramm, C: Signifikante histologische Entzündungsaktivität trotz normwertiger Serum-ALT bei Patienten mit Autoimmuner Hepatitis und Leberzirrhose
P2.23
Mueller, J; Elshaarawy, O; Lan, S; Rausch, V; Seitz, HK; Mueller, S: Critical flicker frequency improves after alcohol abstinence
P2.24
Mueller, J; Rausch, V; Silva, I; Elshaarawy, O; Peccerella, T; Seitz, HK; Mueller, S: Obesity negatively affects LS and CAP resolution after alcohol detoxification in heavy drinkers
P2.25
Nickkholgh, A; GhamarNejad, O; Khajeh, E; Benjamin, G; Hoffmann, K; Mehrabi, A: Liver Resection for Cholangiocarcinoma: Biological and Surgical Predictors of Outcome, Status Quo in Additive Therapy
P2.26
Pascher, A; Morgül, H; Strücker, B; Pratschke, J; Pavel, M; Pape, UF: Minimally invasive versus open hepatic resection for NEN liver metastasis: Case matched study with propensity score matching
P2.27
Praktiknjo, M; Lehmann, J; Nielsen, MJ; Schierwagen, R; Meyer, C; Thomas, D; Strassburg, CP; Bendtsen, F; Möller, S; Krag, A; Karsdal, M; Leeming, D; Trebicka, J: Collagen type IV remodeling gender-specifically predicts mortality in decompensated liver cirrhosis
P2.28
Praktiknjo, M; Pieper, C; Fischer, S; Krabbe, V; Pohlmann, A; Lehmann, J; Böhm, K; Korte, I; Witt, A; Strassburg, CP; Jansen, C; Thomas, D; Meyer, C; Trebicka, J: Underdilation of controlled expansion transjugular intrahepatic portosystemic shunt (TIPS) preserves cardiac function and improves outcome
P2.29
Quickert, S; Reuken, PA; Rose, M; Boden, K; Stallmach, A; Bruns, T: Hepatitis E is a frequent cause of severe acute liver injury – a tertiary referral center experience
P2.30
Ravichandran, G; Neumann, K; Berkhout, L; Weidemann, S; Schwinge, D; Schramm, C; Huber, S; Barikbin, R; Tiegs, G: Interferon-γ-dependent immune responses contribute to the pathogenesis of primary sclerosing cholangitis in mice
P2.31
Reichert, MC; Liebe, R; Casper, M; Schneider, C; Appenrodt, B; Greinert, R; Zipprich, A; Ripoll, C; Lammert, F: Protektiver Effekt von Statinen auf die Entstehung der heptischen Enzephalopathie ist abhängig von häufigen Genvarianten
P2.32
Rinella, M; Ratziu, V; Balp, MM; McKenna, SJ; Przybysz, R; Cai, J; Brass, C; Howe, T; Gavaghan, M; Rosen, D; Knight, A; Geier, A: The journey of a patient with biopsy-proven non-alcoholic steatohepatitis (NASH) – results from a real-world study
P2.33
Schmid, S; Cosma, LS; Denk, A; Müller-Schilling, M: Delirium – of outstanding relevance for the interprofessional team on an intensive care unit with focus on hepatology
P2.34
Schmid, S; Hoppmann, H; Michels, B; Müller-Schilling, M: TIPS placed before current hospitalization and early admission to ICU increase survival of patients with cirrhosis and sepsis
P2.35
Sebode, M; Reike-Kunze, M; Weidemann, S; Zenouzi, R; Hartl, J; Peiseler, M; Liwinski, T; Schulz, L; Weiler-Normann, C; Lohse, AW; Schramm, C: Metamizole: an underrated agent causing drug-induced liver injury (DILI) in Germany
P2.36
Seeßle, J; Löhr, J; Michaelis, J; Merle, U: Thrombelastometry in patients with acute-on-chronic liver failure
P2.37
Thodou, V; Büchetr, M; Kahraman, A: Intravenous therapy of hepatic encephalopathy with L-ornithine l-aspartate (Lola) is safe and very effective
P2.38
Tremmel, R; Helm, F; Wupperfeld, D; Fricker, G; Stremmel, W: Delivery of Copper-chelating Trientine (TETA) to the central nervous system
P2.39
Voitl, R; Hippchen, T; Zhang-Hagenlocher, C; Weiss, KH; Rupp, C: Obeticholic acid for the treatment of primary biliary cholangitis – first data from a real world cohort
P2.40
Voitl, R; Hippchen, T; Zhang-Hagenlocher, C; Weiss, KH; Rupp, C: The rs626283 Variant in the MBOAT7 Gene is Associated with reduced survival in primary biliary cholangitis
P2.41
Wang, S; Feng, R; Yuan, X; Wandrer, F; Ebert, MP; Bantel, H; Li, H; Dooley, S; Weng, HL: Maintenance of functional hepatocellular polarity determines recovery in acute-on-chronic liver failure
P2.42
Weiss, J; Datz, B; Kern, L; Kudlich, T; Pinter, M; Rau, M; Götze, O; Klein, I; Michael, T; Geier, A: A simple clinical score to predict survival in patients with hepatocellular carcinoma